The researchers suggest future prospective studies of acute relapse and disease-modifying treatment courses during and after pregnancy to ultimately improve treatment regimens for patients with NMOSD.
A proper MS diagnosis can only be made after obtaining imaging from the entire brain and understanding the clinical context.
In women with NMOSD, 42.9% of pregnancies ended in miscarriage compared with 12-24% in the general population.
Neurology Advisor Articles
- McDonald Criteria Update: Further Distinction Between Relapsing-Remitting, Primary-Progressive MS
- Distinct Clinical Characteristics of Headache Associated With Subarachnoid Hemorrhage
- Increased Epilepsy Risk Identified in Multiple Sclerosis
- Magnesium Plus Environmental Enrichment Boosts Cognition, Memory in Alzheimer's Mouse Model
- Prognostic Significance of Weight Loss in Patients With Early Parkinsonism
- Coffee Consumption May Decrease Stroke Risk
- When and How to Approach Driving Cessation in Patients With Dementia
- NBT System Gets FDA Clearance for Depression Treatment
- Erenumab, Fremanezumab Reduce Migraine Frequency, Burden
- Some Antiepileptic Drugs Associated With Increased Risk for Toxic Epidermal Necrolysis
- Obesity and Alzheimer Disease: Exploring Risk Modification
- Increased Amyloid Burden With Obstructive Sleep Apnea
- Vigabatrin Beneficial for Focal Seizures in Tuberous Sclerosis Complex
- Number of Americans With Alzheimer Disease Expected to More Than Double by 2060
- Deep Brain Stimulation Improves Survival in Parkinson Disease